Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 5/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.33 |
| ▸ | AURKA | O14965 | 5/20 | 0.33 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | BRAF | P15056 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26101647 | 1.00 | TYK2 (0.33) | TYK2PDE4DAURKAPDE1BCNR2 | |
| SCHEMBL26101644 | 1.00 | TYK2 (0.33) | TYK2PDE4DAURKAPDE1BCNR2 | |
| SCHEMBL26100963 | 0.92 | TYK2 (0.40) | TYK2PDE4D | |
| SCHEMBL30391424 | 0.92 | TYK2 (0.35) | TYK2PDE4DAURKAPDE1BCNR2 | |
| SCHEMBL26101565 | 0.91 | TYK2 (0.39) | TYK2PDE4DAURKACNR2 | |
| SCHEMBL30392105 | 0.91 | TYK2 (0.33) | TYK2PDE4DAURKANPC1RAB9A | |
| SCHEMBL26098951 | 0.91 | TYK2 (0.33) | TYK2PDE4DAURKANPC1RAB9A | |
| SCHEMBL30392913 | 0.91 | TYK2 (0.33) | TYK2PDE4DAURKANPC1RAB9A | |
| SCHEMBL30392536 | 0.91 | TYK2 (0.38) | TYK2PDE4DAURKANPC1RAB9A | |
| SCHEMBL26097861 | 0.91 | TYK2 (0.38) | TYK2PDE4DAURKANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4423086-A1 | TYK2 DEGRADERS AND USES THEREOF | Kymera Therapeutics, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2023076161-A1 | TYK2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-05-04 | — | — | WO | disclosed |